Sanofi-Aventis Sees A Bright Future In Boston-CambridgeSanofi CEO Chris Viehbacher says research departments have been consolidated here to be near universities.
It's A Done Deal For GenzymeAfter nine months of denials, rejection, bickering and finally, discussion, French pharmaceutical company Sanofi-Aventis of Paris has signed a deal to buy Genzyme of Cambridge for $20.1 billion plus other milestone payments in the future.
Genzyme Sold To Sanofi-Aventis In $20 Billion DealCambridge-based biotechnology company Genzyme is being bought by French drug maker Sanofi-Aventis for $20.1 billion, ending months of corporate haggling.
Genzyme Rejects Latest Sanofi OfferSanofi-Aventis extended its unsolicited $18.5 billion takeover offer for Cambridge biotech company Genzyme Corp. Monday.
Talk of possible Genzyme sale heating up

More From CBS Boston

Download Our App
Download Weather App
Taz Show

Listen Live